Rohto Pharmaceutical Co (4527) Price & Analysis

Compare

1 Followers

4527 Stock Chart & Stats

Day’s Range― - ―

52-Week Range¥1,964.50 - ¥3,615.00

Previous CloseN/A

Volume733.70K

Average Volume (3M)679.46K

Market Cap

¥592.70B

Enterprise Value¥452.54B

Total Cash (Recent Filing)¥61.71B

Total Debt (Recent Filing)¥38.81B

Price to Earnings (P/E)16.9

Beta0.55

Next Earnings

Nov 06, 2025

EPS Estimate

24.98

Last Dividend Ex-Date

Sep 29, 2025

Dividend Yield1.41%

Share Statistics

EPS (TTM)52.09

Shares Outstanding236,178,310

10 Day Avg. Volume512,590

30 Day Avg. Volume679,456

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

¥2,774.45

Price Target Upside8.67% Upside

Rating ConsensusHold

Number of Analyst Covering4

Rohto Pharmaceutical Co News

Rohto Pharmaceutical Revises Earnings Forecast Upward

Rohto Pharmaceutical Co ( ($JP:4527) ) has issued an announcement. Rohto Pharmaceutical Co., Ltd. has revised its earnings...

2M ago

Rohto Pharmaceutical Reports Strong Q1 Financial Performance with Revised Forecast

The latest announcement is out from Rohto Pharmaceutical Co ( ($JP:4527) ). Rohto Pharmaceutical Co. reported a significant...

2M ago

Rohto Pharmaceutical Announces Dividend Increase

Rohto Pharmaceutical Co ( ($JP:4527) ) just unveiled an announcement. Rohto Pharmaceutical Co., Ltd. announced a resolution to...

4M ago

Rohto Pharmaceutical Reports Strong Sales Growth

Rohto Pharmaceutical Co ( ($RPHCF) ) has released its Q4 earnings. Here is a breakdown of the information...

5M ago

Rohto Pharmaceutical Unveils 2025-2035 Growth Strategy

Rohto Pharmaceutical Co ( ($JP:4527) ) has issued an update. Rohto Pharmaceutical Co., Ltd. has announced its Medium-...

5M ago

Rohto Pharmaceutical Reports FY2025 Financial Results with Increased Sales and Dividends

An update from Rohto Pharmaceutical Co ( ($JP:4527) ) is now available. Rohto Pharmaceutical Co. reported its consolidated...

5M ago

RPHCF Earnings this Week: How Will it Perform?

Rohto Pharmaceutical Co (RPHCF) is scheduled to report 4th quarter earnings on 05/13/2025. Regarding Q4 estimates, Wall Street...

5M ago

Rohto Pharmaceutical Announces Leadership Changes to Drive Future Growth

Rohto Pharmaceutical Co ( ($JP:4527) ) has provided an announcement. Rohto Pharmaceutical Co., Ltd. announced significant leadership changes,...

5M ago

Rohto Pharmaceutical Completes Strategic Share Repurchase

The latest update is out from Rohto Pharmaceutical Co ( ($JP:4527) ). Rohto Pharmaceutical Co., Ltd. announced the...

7M ago

Rohto Pharmaceutical Announces Terms for 2032 Convertible Bonds

Rohto Pharmaceutical Co ( ($JP:4527) ) just unveiled an announcement. Rohto Pharmaceutical Co., Ltd. has announced the terms...

7M ago

Rohto Pharmaceutical downgraded to Underperform from Buy at Jefferies

Jefferies analyst Hisae Kawamoto downgraded Rohto Pharmaceutical (RPHCF) to Underperform from Buy with a price target of 2,450...

10M ago

Rohto Pharmaceutical initiated with a Buy at Jefferies

Jefferies initiated coverage of Rohto Pharmaceutical with a Buy rating and 3,900 yen price target. The analyst initiated...

1y ago

4527 FAQ

What was Rohto Pharmaceutical Co’s price range in the past 12 months?

Rohto Pharmaceutical Co lowest stock price was ¥1964.50 and its highest was ¥3615.00 in the past 12 months.

What is Rohto Pharmaceutical Co’s market cap?

Rohto Pharmaceutical Co’s market cap is ¥592.70B.

When is Rohto Pharmaceutical Co’s upcoming earnings report date?

Rohto Pharmaceutical Co’s upcoming earnings report date is Nov 06, 2025 which is in 37 days.

How were Rohto Pharmaceutical Co’s earnings last quarter?

Rohto Pharmaceutical Co released its earnings results on Aug 12, 2025. The company reported ¥52.09 earnings per share for the quarter, beating the consensus estimate of N/A by ¥52.09.

Is Rohto Pharmaceutical Co overvalued?

According to Wall Street analysts Rohto Pharmaceutical Co’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Rohto Pharmaceutical Co pay dividends?

Rohto Pharmaceutical Co pays a Semiannually dividend of ¥21 which represents an annual dividend yield of 1.41%. See more information on Rohto Pharmaceutical Co dividends here

What is Rohto Pharmaceutical Co’s EPS estimate?

Rohto Pharmaceutical Co’s EPS estimate is 24.98.

How many shares outstanding does Rohto Pharmaceutical Co have?

Rohto Pharmaceutical Co has 236,178,310 shares outstanding.

What happened to Rohto Pharmaceutical Co’s price movement after its last earnings report?

Rohto Pharmaceutical Co reported an EPS of ¥52.09 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.54%.

Which hedge fund is a major shareholder of Rohto Pharmaceutical Co?

Currently, no hedge funds are holding shares in JP:4527

Company Description

Rohto Pharmaceutical Co

Rohto Pharmaceutical Co., Ltd. is a Japanese multinational company headquartered in Osaka, Japan. Established in 1899, the company operates primarily in the pharmaceuticals and healthcare sectors. Rohto is renowned for its extensive range of over-the-counter (OTC) drugs, skincare products, and other consumer healthcare goods. Its core product lineup includes eye drops, skincare items, gastrointestinal medications, and topical anti-inflammatory products. The company has a significant presence in Asia, North America, and Europe, and continues to expand its market reach globally.

Rohto Pharmaceutical Co (4527) Earnings & Revenues

Historic Earnings Reports

4527 Stock 12 Month Forecast

Average Price Target

¥2,774.45

▲(8.67% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1625":"¥1,625","3820":"¥3,820","2173.75":"¥2,173.8","2722.5":"¥2,722.5","3271.25":"¥3,271.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3499.85043369,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥3.50K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2774.4540831175,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥2.77K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1999.7008674545,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥2.00K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1625,2173.75,2722.5,3271.25,3820],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2541.5,2615.21926413,2688.93852826,2762.65779239,2836.37705652,2910.09632065,2983.81558478,3057.5348489099997,3131.25411304,3204.9733771700003,3278.6926413,3352.41190543,3426.1311695599998,{"y":3499.85043369,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2541.5,2559.4195448551923,2577.3390897103845,2595.258634565577,2613.178179420769,2631.0977242759614,2649.0172691311536,2666.9368139863464,2684.8563588415386,2702.775903696731,2720.695448551923,2738.6149934071154,2756.5345382623077,{"y":2774.4540831175,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2541.5,2499.823143650346,2458.146287300692,2416.4694309510382,2374.792574601385,2333.115718251731,2291.438861902077,2249.762005552423,2208.085149202769,2166.408292853115,2124.7314365034617,2083.054580153808,2041.377723804154,{"y":1999.7008674545,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1626.374,"date":1633046400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3819.935,"date":1693526400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3041.754,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3351.69,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3300.183,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2882.828,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2151.712,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2247.5,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2388,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2020.5,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2047,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2180,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2541.5,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >